Barclays Maintains Overweight on JBS, Lowers Price Target to $21
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $23 to $21.
Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $23 to $21.